{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:35:41Z","timestamp":1747157741284,"version":"3.40.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalimaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.clinimag.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T02:02:08Z","timestamp":1423706528000},"page":"632-635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of R-CHOP chemotherapy on liver and mediastinal blood pool 18F-FDG standardized uptake values in patients with non-Hodgkin\u2019s lymphoma"],"prefix":"10.1016","volume":"39","author":[{"given":"Bugra","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeki","family":"Dostbil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Ismailoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-0341","authenticated-orcid":false,"given":"Bekir","family":"Tasdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2015.02.006_bb0005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2214\/AJR.10.4679","article-title":"Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET\/CT","volume":"196","author":"Abikhzer","year":"2011","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0010","first-page":"1795","article-title":"18F-FDG PET in characterizing adrenal lesions detected on CT or MRI","volume":"42","author":"Yun","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0015","first-page":"2058","article-title":"18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer","volume":"45","author":"Kumar","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0020","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1200\/JCO.2009.22.4089","article-title":"Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials","volume":"27","author":"Meignan","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0025","first-page":"1123","article-title":"Factors affecting intrapatient liver and mediastinal blood pool 18F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma","volume":"41","author":"Chiaravalloti","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0030","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1182\/blood.V91.9.3340","article-title":"Detection of lymphoma in bone marrow by whole-body positron emission tomography","volume":"91","author":"Carr","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0035","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/thx.2006.072959","article-title":"Integrated FDGPET\/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study","volume":"62","author":"Tournoy","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0040","first-page":"1784","article-title":"Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma","volume":"40","author":"Delbeke","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0045","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00259-004-1757-9","article-title":"The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease","volume":"32","author":"Walter","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0050","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2967\/jnumed.107.040436","article-title":"Noninvasive assessment of Crohn\u2019s disease intestinal lesions with (18)F-FDG PET\/CT","volume":"48","author":"Louis","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0055","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12149-009-0286-9","article-title":"A bone marrow F-18FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity","volume":"23","author":"Inoue","year":"2009","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0060","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.rcl.2005.05.008","article-title":"Applications of PET in liver imaging","volume":"43","author":"Khandani","year":"2005","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0972-3919.108835","article-title":"Multivariate analysis of various factors affecting background liver and mediastinal standardized uptake values","volume":"27","author":"Kuruva","year":"2012","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0070","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0075","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.2013.103218","article-title":"The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale","volume":"99","author":"Gallamini","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bjh.12601","article-title":"When should FDG-PET be used in the modern management of lymphoma?","volume":"164","author":"Barrington","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0085","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/annonc\/mdi272","article-title":"FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma","volume":"16","author":"Mikhaeel","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0090","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2967\/jnumed.112.110890","article-title":"International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers","volume":"54","author":"Biggi","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0095","first-page":"784","article-title":"Within-patient variability of 18F-FDG: standardized uptake values in normal tissues","volume":"45","author":"Paquet","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1475-097X.2008.00846.x","article-title":"Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans","volume":"29","author":"Kanstrup","year":"2009","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0105","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1179\/1607845413Y.0000000147","article-title":"Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era","volume":"19","author":"Zaky","year":"2014","journal-title":"Hematology"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1078155206072982","article-title":"Laboratory monitoring in oncology","volume":"12","author":"Duong","year":"2006","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0115","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/RLU.0b013e318263831d","article-title":"18F-FDG uptake changes in liver and mediastinum during chemotherapy in patients with diffuse large B-cell lymphoma","volume":"37","author":"Ceriani","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/RLU.0b013e3182872f0e","article-title":"Variation of liver SUV on (18)FDG-PET\/CT studies in women with breast cancer","volume":"38","author":"Groheux","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.clinimag.2015.02.006_bb0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nucmedbio.2010.09.004","article-title":"Effects of blood glucose level on FDG uptake by liver: a FDG-PET\/CT study","volume":"38","author":"Kubota","year":"2011","journal-title":"Nucl Med Biol"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707115000492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707115000492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T22:59:31Z","timestamp":1598741971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707115000492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0899707115000492"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2015.02.006","relation":{},"ISSN":["0899-7071"],"issn-type":[{"type":"print","value":"0899-7071"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of R-CHOP chemotherapy on liver and mediastinal blood pool 18F-FDG standardized uptake values in patients with non-Hodgkin\u2019s lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}